13F HOLDINGS REPORT
Medicxi Ventures Management (Jersey) Ltd
Quarter ended Q4 2024 · Filed January 23, 2025 · Accession 0000950123-25-000517
Total Value
$529.0M
Positions
5
Other Managers
1
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $334.4M | 63.20% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $73.7M | 13.94% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $60.6M | 11.46% |
| 4 | RAPT THERAPEUTICS INC | 75382E109 | 22,352,000 | $35.3M | 6.68% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $25.0M | 4.72% |